2015 Asthma Capitals


Coming soon!
We are currently working on the 2018 Asthma Capitals. Watch for the new list on this page, our blog and on social media on World Asthma Day, May 1, 2018.


Asthma is a chronic disease where the airways swell. This causes wheezing, coughing and other symptoms that make it hard to breathe. With the right diagnosis, treatment and care, people can manage their asthma. This can lead to less severe attacks, better lung function and better breathing, no matter where they live.

Control Asthma Everywhere, Every Day

The Asthma Capitals™ report is a yearly research project of AAFA. We research the most challenging places to live in the U.S. We rank the 100 largest U.S. metro areas. We rank each city by looking at 13 important factors. These include how often asthma occurs, environmental conditions and health care use.

2015 Asthma Capitals

The five most challenging cities to live in with asthma this year are:

  1. Memphis, Tennessee
  2. Richmond, Virginia
  3. Philadelphia, Pennsylvania
  4. Detroit, Michigan
  5. Oklahoma City, Oklahoma

Several major factors put Memphis’ in the top Asthma Capital spot this year. These include poor air quality, poor public smoking bans, high use of asthma medicines and a lot of emergency room visits for asthma.

Download our full report Download PDF of  the top 100 Asthma Capitals™ and learn about the way we ranked them.

AAFA’s Asthma Capitals™ report helps cities see the political, environmental and health care effects of asthma. We are happy that this report helps people nationally and locally. The Asthma Capitals is helping protect the quality of life for asthma patients. It is also improving the economic effects asthma has on the nation.

There is no cure for asthma. But you can manage it with the right prevention and treatment. Talk to your doctor about the best treatment.

Where Can I Get More Information About the 2015 Rankings?

2015 Asthma Capitals - 100 Metro Areas and Regional Rankings Download PDF

Press Release Download PDF



AAFA’s 2015 Asthma Capitals report was sponsored this year by Teva Respiratory and QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol. Please see full prescribing information at .


Special thanks to our research partner, a division of IMS Health.